Arvinas, Inc. (ARVN)
8.29
-0.02
(-0.24%)
USD |
NASDAQ |
Sep 18, 16:00
8.26
-0.03
(-0.36%)
Pre-Market: 08:56
Arvinas Net Income (TTM) : 9.30M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.30M |
| March 31, 2026 | -221.30M |
| December 31, 2025 | -80.80M |
| September 30, 2025 | -58.50M |
| June 30, 2025 | -72.60M |
| March 31, 2025 | -46.60M |
| December 31, 2024 | -198.90M |
| September 30, 2024 | -308.60M |
| June 30, 2024 | -323.40M |
| March 31, 2024 | -354.80M |
| December 31, 2023 | -367.30M |
| September 30, 2023 | -295.40M |
| June 30, 2023 | -297.60M |
| March 31, 2023 | -301.00M |
| December 31, 2022 | -282.50M |
| September 30, 2022 | -252.60M |
| June 30, 2022 | -233.15M |
| March 31, 2022 | -213.44M |
| Date | Value |
|---|---|
| December 31, 2021 | -191.00M |
| September 30, 2021 | -179.55M |
| June 30, 2021 | -163.62M |
| March 31, 2021 | -138.56M |
| December 31, 2020 | -119.33M |
| September 30, 2020 | -98.83M |
| June 30, 2020 | -85.69M |
| March 31, 2020 | -77.63M |
| December 31, 2019 | -70.29M |
| September 30, 2019 | -65.33M |
| June 30, 2019 | -61.04M |
| March 31, 2019 | -51.73M |
| December 31, 2018 | -41.48M |
| September 30, 2018 | -30.12M |
| June 30, 2018 | -23.13M |
| March 31, 2018 | -21.95M |
| December 31, 2017 | -24.05M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Cocrystal Pharma, Inc. | -9.938M |
| CNBX Pharmaceuticals, Inc. | -0.4621M |
| GB Sciences, Inc. | -- |
| Fulcrum Therapeutics, Inc. | -85.00M |
| Definium Therapeutics, Inc. | -353.78M |